These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16228906)

  • 1. Dystrophin and the cardiomyocyte membrane cytoskeleton in the healthy and failing heart.
    Kaprielian RR; Severs NJ
    Heart Fail Rev; 2000 Oct; 5(3):221-38. PubMed ID: 16228906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte cytoskeleton and myofibrillogenesis in healthy and diseased heart.
    Ehler E; Perriard JC
    Heart Fail Rev; 2000 Oct; 5(3):259-69. PubMed ID: 16228909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of dystrophin organization in myocyte sarcolemma and transverse tubules of normal and diseased human myocardium.
    Kaprielian RR; Stevenson S; Rothery SM; Cullen MJ; Severs NJ
    Circulation; 2000 Jun; 101(22):2586-94. PubMed ID: 10840009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytoskeleton and related proteins in the human failing heart.
    Kostin S; Hein S; Arnon E; Scholz D; Schaper J
    Heart Fail Rev; 2000 Oct; 5(3):271-80. PubMed ID: 16228910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
    Jung C; Martins AS; Niggli E; Shirokova N
    Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification.
    Elsherif L; Huang MS; Shai SY; Yang Y; Li RY; Chun J; Mekany MA; Chu AL; Kaufman SJ; Ross RS
    Circ Res; 2008 May; 102(9):1109-17. PubMed ID: 18340010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies.
    Shirokova N; Niggli E
    J Mol Cell Cardiol; 2013 May; 58():217-24. PubMed ID: 23261966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution en-face visualization of the cardiomyocyte plasma membrane reveals distinctive distributions of spectrin and dystrophin.
    Stevenson SA; Cullen MJ; Rothery S; Coppen SR; Severs NJ
    Eur J Cell Biol; 2005 Dec; 84(12):961-71. PubMed ID: 16325505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin: from non-ischemic cardiomyopathy to ischemic cardiomyopathy.
    Zheng QS; Guo WG; Lu ZF; Shi XQ; Su FF; Li H
    Med Hypotheses; 2008 Sep; 71(3):434-8. PubMed ID: 18562127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage.
    Lorin C; Vögeli I; Niggli E
    Cardiovasc Res; 2015 Apr; 106(1):153-62. PubMed ID: 25616416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-decorated dystrophin molecule of murine skeletal myofiber as seen by freeze-etching electron microscopy.
    Wakayama Y; Shibuya S
    J Electron Microsc (Tokyo); 1991 Apr; 40(2):143-5. PubMed ID: 1895031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystrophin is required for the normal function of the cardio-protective K(ATP) channel in cardiomyocytes.
    Graciotti L; Becker J; Granata AL; Procopio AD; Tessarollo L; Fulgenzi G
    PLoS One; 2011; 6(10):e27034. PubMed ID: 22066028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice.
    Yue Y; Skimming JW; Liu M; Strawn T; Duan D
    Hum Mol Genet; 2004 Aug; 13(15):1669-75. PubMed ID: 15190010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophin is not a specific component of the cardiac costamere.
    Stevenson S; Rothery S; Cullen MJ; Severs NJ
    Circ Res; 1997 Feb; 80(2):269-80. PubMed ID: 9012749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the cytoskeleton in heart failure.
    Hein S; Kostin S; Heling A; Maeno Y; Schaper J
    Cardiovasc Res; 2000 Jan; 45(2):273-8. PubMed ID: 10728347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes.
    Fanchaouy M; Polakova E; Jung C; Ogrodnik J; Shirokova N; Niggli E
    Cell Calcium; 2009 Aug; 46(2):114-21. PubMed ID: 19604578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
    Chun JL; O'Brien R; Berry SE
    Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin-glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling.
    Garbincius JF; Michele DE
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13663-8. PubMed ID: 26483453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy.
    Chang AC; Ong SG; LaGory EL; Kraft PE; Giaccia AJ; Wu JC; Blau HM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13120-13125. PubMed ID: 27799523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal structure and remodeling in dystrophin-deficient cardiomyocytes using second harmonic generation.
    Varga B; Meli AC; Radoslavova S; Panel M; Lacampagne A; Gergely C; Cazorla O; Cloitre T
    Nanomedicine; 2020 Nov; 30():102295. PubMed ID: 32889047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.